共 23 条
- [12] Alternative Analysis Methods for Time to Event Endpoints Under Nonproportional Hazards: A Comparative Analysis [J]. STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2020, 12 (02): : 187 - 198
- [13] Lin RS, 2017, CONT CLIN TRIAL COMM, V8, P147, DOI 10.1016/j.conctc.2017.09.004
- [15] Ristl Robin, 2022, CRAN, DOI 10.32614/CRAN.package.nph
- [16] Robust Design and Analysis of Clinical Trials With Nonproportional Hazards: A Straw Man Guidance From a Cross-Pharma Working Group [J]. STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2023, 15 (02): : 280 - 294
- [20] SurvBin R package, 2020, Two-sample statistics for binary and time-to-event outcomes